STEMI Antithrombotic Therapy: The Evolving Role of P2Y12 Inhibitor Pretreatment in Contemporary Practice
The P2Y12 receptor plays a central role in platelet activation, secretion, and procoagulant activity. The CURE (clopidogrel in unstable angina to prevent recurrent events) trial, conducted in 2001, was the first to effectively demonstrate the benefit of dual anti-aggregation therapy with aspirin and...
| Published in: | Reviews in Cardiovascular Medicine |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2024-11-01
|
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/RCM/25/11/10.31083/j.rcm2511416 |
